 Teresa Sharp
Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Public-Private Sector Partnerships | 1 | 2019 | 44 | 0.600 |
Why?
| | Geriatric Nursing | 1 | 2019 | 22 | 0.600 |
Why?
| | Health Resources | 1 | 2019 | 131 | 0.550 |
Why?
| | Rural Health Services | 1 | 2019 | 141 | 0.550 |
Why?
| | Rural Population | 1 | 2019 | 657 | 0.420 |
Why?
| | Exercise | 13 | 2015 | 2206 | 0.420 |
Why?
| | Energy Metabolism | 14 | 2012 | 946 | 0.410 |
Why?
| | Homosexuality, Male | 1 | 2015 | 223 | 0.390 |
Why?
| | Healthcare Disparities | 1 | 2019 | 736 | 0.370 |
Why?
| | Attitude to Health | 1 | 2015 | 436 | 0.340 |
Why?
| | Health Services Accessibility | 1 | 2019 | 1104 | 0.330 |
Why?
| | Basal Metabolism | 3 | 2006 | 63 | 0.210 |
Why?
| | Dietary Carbohydrates | 4 | 2006 | 151 | 0.190 |
Why?
| | Calorimetry, Indirect | 9 | 2006 | 83 | 0.190 |
Why?
| | Harm Reduction | 1 | 2023 | 51 | 0.190 |
Why?
| | Body Composition | 10 | 2006 | 708 | 0.180 |
Why?
| | Dietary Fats | 5 | 2006 | 315 | 0.180 |
Why?
| | Substance Abuse, Intravenous | 1 | 2023 | 128 | 0.170 |
Why?
| | Obesity | 8 | 2012 | 3085 | 0.170 |
Why?
| | Body Weight | 5 | 2003 | 980 | 0.150 |
Why?
| | Health Policy | 1 | 2023 | 401 | 0.150 |
Why?
| | Adiponectin | 2 | 2016 | 244 | 0.130 |
Why?
| | Cholesterol | 2 | 2012 | 408 | 0.120 |
Why?
| | Human Development | 1 | 2016 | 21 | 0.120 |
Why?
| | Triglycerides | 2 | 2012 | 521 | 0.120 |
Why?
| | Physical Fitness | 2 | 2000 | 209 | 0.120 |
Why?
| | Adipose Tissue | 4 | 2006 | 653 | 0.110 |
Why?
| | Puberty | 1 | 2016 | 140 | 0.110 |
Why?
| | Diabetes Mellitus | 1 | 2003 | 1098 | 0.110 |
Why?
| | Canada | 1 | 2015 | 429 | 0.100 |
Why?
| | Fats | 3 | 2002 | 17 | 0.100 |
Why?
| | Regression Analysis | 3 | 2003 | 1003 | 0.090 |
Why?
| | United States | 3 | 2023 | 16051 | 0.090 |
Why?
| | Male | 20 | 2019 | 72629 | 0.090 |
Why?
| | Hyperlipidemias | 1 | 2012 | 122 | 0.090 |
Why?
| | Thinness | 1 | 2012 | 99 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2003 | 2182 | 0.080 |
Why?
| | Self Efficacy | 1 | 2015 | 414 | 0.080 |
Why?
| | Oxygen Consumption | 3 | 2008 | 725 | 0.080 |
Why?
| | Adult | 18 | 2016 | 40627 | 0.080 |
Why?
| | Weight Loss | 2 | 2008 | 838 | 0.080 |
Why?
| | Physical Endurance | 3 | 2002 | 278 | 0.070 |
Why?
| | Circadian Rhythm | 2 | 2005 | 514 | 0.070 |
Why?
| | Oxidation-Reduction | 8 | 2005 | 1087 | 0.070 |
Why?
| | Middle Aged | 7 | 2019 | 36021 | 0.070 |
Why?
| | Metabolic Syndrome | 1 | 2012 | 356 | 0.070 |
Why?
| | Pharynx | 1 | 2008 | 59 | 0.070 |
Why?
| | Energy Intake | 4 | 2008 | 508 | 0.070 |
Why?
| | Female | 19 | 2019 | 78605 | 0.070 |
Why?
| | Humans | 23 | 2023 | 145307 | 0.070 |
Why?
| | Insulin Resistance | 1 | 2016 | 1243 | 0.070 |
Why?
| | Motor Activity | 1 | 2012 | 725 | 0.060 |
Why?
| | Sleep | 4 | 2008 | 901 | 0.060 |
Why?
| | Aged, 80 and over | 1 | 2019 | 8295 | 0.060 |
Why?
| | Weight Gain | 2 | 2012 | 564 | 0.060 |
Why?
| | Carbohydrate Metabolism | 2 | 2002 | 61 | 0.060 |
Why?
| | Young Adult | 4 | 2016 | 14163 | 0.060 |
Why?
| | Obesity, Morbid | 1 | 2008 | 288 | 0.050 |
Why?
| | Dietary Proteins | 1 | 2005 | 136 | 0.050 |
Why?
| | HIV-Associated Lipodystrophy Syndrome | 1 | 2003 | 11 | 0.050 |
Why?
| | Lipoproteins, HDL | 1 | 2003 | 101 | 0.050 |
Why?
| | Anthropometry | 1 | 2003 | 200 | 0.050 |
Why?
| | Calcium, Dietary | 1 | 2003 | 53 | 0.050 |
Why?
| | Body Mass Index | 4 | 2003 | 2439 | 0.050 |
Why?
| | Weight Lifting | 1 | 2002 | 32 | 0.050 |
Why?
| | Surveys and Questionnaires | 1 | 2015 | 6079 | 0.040 |
Why?
| | Physical Exertion | 1 | 2002 | 207 | 0.040 |
Why?
| | Body Height | 1 | 2002 | 202 | 0.040 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2001 | 98 | 0.040 |
Why?
| | Cross-Over Studies | 3 | 2012 | 610 | 0.040 |
Why?
| | Cooperative Behavior | 1 | 2023 | 467 | 0.040 |
Why?
| | Sex Characteristics | 2 | 2002 | 791 | 0.040 |
Why?
| | Blood Pressure | 2 | 2003 | 1771 | 0.040 |
Why?
| | Calorimetry | 3 | 2008 | 72 | 0.040 |
Why?
| | Bicycling | 2 | 2005 | 120 | 0.040 |
Why?
| | Aged | 1 | 2019 | 26001 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2003 | 529 | 0.040 |
Why?
| | Adolescent | 6 | 2016 | 22507 | 0.040 |
Why?
| | Blood Glucose | 2 | 2012 | 2333 | 0.040 |
Why?
| | Sex Factors | 2 | 2016 | 2115 | 0.030 |
Why?
| | Cross-Sectional Studies | 3 | 2016 | 5883 | 0.030 |
Why?
| | Carbon Dioxide | 2 | 2008 | 242 | 0.030 |
Why?
| | Physical Education and Training | 1 | 1994 | 71 | 0.030 |
Why?
| | Eating | 2 | 1994 | 392 | 0.020 |
Why?
| | Hypertension | 1 | 2001 | 1266 | 0.020 |
Why?
| | Aerobiosis | 1 | 1992 | 22 | 0.020 |
Why?
| | Insulin | 3 | 2012 | 2507 | 0.020 |
Why?
| | Overnutrition | 1 | 2012 | 30 | 0.020 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2012 | 158 | 0.020 |
Why?
| | Postprandial Period | 1 | 2012 | 118 | 0.020 |
Why?
| | Rest | 1 | 1992 | 124 | 0.020 |
Why?
| | Area Under Curve | 1 | 2012 | 332 | 0.020 |
Why?
| | Aging | 1 | 2002 | 1968 | 0.020 |
Why?
| | Body Temperature | 1 | 1992 | 229 | 0.020 |
Why?
| | Accelerometry | 1 | 2012 | 119 | 0.020 |
Why?
| | Risk Factors | 1 | 2003 | 10816 | 0.020 |
Why?
| | Diet | 3 | 2003 | 1285 | 0.020 |
Why?
| | Sleep Apnea Syndromes | 1 | 2008 | 97 | 0.020 |
Why?
| | Colorado | 1 | 2016 | 4579 | 0.010 |
Why?
| | Glucose Clamp Technique | 1 | 2006 | 199 | 0.010 |
Why?
| | Pulmonary Gas Exchange | 1 | 2005 | 119 | 0.010 |
Why?
| | Respiration | 1 | 2005 | 207 | 0.010 |
Why?
| | Linear Models | 1 | 2006 | 854 | 0.010 |
Why?
| | Dairy Products | 1 | 2003 | 31 | 0.010 |
Why?
| | Anaerobic Threshold | 1 | 2002 | 28 | 0.010 |
Why?
| | Lipolysis | 1 | 2003 | 46 | 0.010 |
Why?
| | Sampling Studies | 1 | 2002 | 99 | 0.010 |
Why?
| | CD4 Lymphocyte Count | 1 | 2003 | 278 | 0.010 |
Why?
| | Abdomen | 1 | 2003 | 141 | 0.010 |
Why?
| | Glucose Tolerance Test | 1 | 2003 | 361 | 0.010 |
Why?
| | Renin | 1 | 2001 | 34 | 0.010 |
Why?
| | Aldosterone | 1 | 2001 | 43 | 0.010 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2001 | 48 | 0.010 |
Why?
| | Reference Values | 1 | 2002 | 798 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 7186 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2006 | 2118 | 0.010 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2001 | 142 | 0.010 |
Why?
| | Kinetics | 1 | 2003 | 1630 | 0.010 |
Why?
| | Fatty Acids | 1 | 2001 | 452 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2001 | 1311 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2002 | 1992 | 0.010 |
Why?
| | Heart Rate | 1 | 2001 | 857 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2926 | 0.010 |
Why?
| | Lipids | 1 | 2001 | 712 | 0.010 |
Why?
| | Proteins | 1 | 2002 | 1026 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2006 | 5431 | 0.010 |
Why?
| | Child | 1 | 2016 | 22712 | 0.010 |
Why?
| | Menstruation | 1 | 1994 | 42 | 0.010 |
Why?
| | Retrospective Studies | 1 | 1992 | 17149 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2002 | 1800 | 0.010 |
Why?
| | Nutritional Status | 1 | 1994 | 354 | 0.010 |
Why?
| | Prospective Studies | 1 | 2002 | 8011 | 0.000 |
Why?
|
|
Sharp's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|